Home
Platform
Programs
Biodefense
Oncology
Neurology
Epilepsy
PD
Alcohol Use Disorder
Research
About Us
Investors
CONTACT US
News
Latest on Lunai bioworks
SEC Filings
Stock InformatioN
Governance
Ready
2025
2026
2027
2028+
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
January 23, 2026
Lunai Bioworks
Reflections from JPM: a Turning Point for Platform Companies Like Lunai Bioworks
October 30, 2025
ACCESS Newswire
Lunai Bioworks Harnesses AI and Zebrafish Data to Advance Early Detection of Neurotoxic Compounds
October 16, 2025
Newswire
Landmark Study Identifies Prognostic Biomarkers in Duchenne Muscular Dystrophy Using Large-Scale Serum Proteomics
October 16, 2025
Newswire
Lunai Bioworks Regains Compliance with Nasdaq Minimum Bid Price Requirement
September 30, 2025
ACCESSWIRE
Lunai Bioworks Unveils New Corporate Identity, Streamlined Capital Structure, and Strategic Focus on AI-Powered Therapeutics and Biodefense
September 25, 2025
ACCESS Newswire
Lunai Bioworks Advances Biomarker Discovery Preclinical Program in Parkinson's Disease, Positioning for Strategic Pharma Partnerships
September 24, 2025
Newswire
Lunai Bioworks, Inc. to Effect 10:1 Reverse Stock Split
September 9, 2025
Accesswire
Lunai Bioworks Inc. Unveils Transformer Platform to Secure Generative AI and Accelerate Drug Discovery
Load more
.png)
.avif)
